3-193514750-T-C
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_032279.4(ATP13A4):āc.182A>Gā(p.His61Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00355 in 1,614,170 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_032279.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP13A4 | NM_032279.4 | c.182A>G | p.His61Arg | missense_variant | 2/30 | ENST00000342695.9 | NP_115655.2 | |
ATP13A4 | XM_047449063.1 | c.311A>G | p.His104Arg | missense_variant | 4/32 | XP_047305019.1 | ||
ATP13A4 | XM_017007319.2 | c.311A>G | p.His104Arg | missense_variant | 4/27 | XP_016862808.2 | ||
ATP13A4 | XR_007095757.1 | n.575A>G | non_coding_transcript_exon_variant | 4/26 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP13A4 | ENST00000342695.9 | c.182A>G | p.His61Arg | missense_variant | 2/30 | 1 | NM_032279.4 | ENSP00000339182 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00233 AC: 355AN: 152168Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00241 AC: 606AN: 251418Hom.: 1 AF XY: 0.00222 AC XY: 301AN XY: 135880
GnomAD4 exome AF: 0.00368 AC: 5379AN: 1461884Hom.: 15 Cov.: 31 AF XY: 0.00355 AC XY: 2579AN XY: 727242
GnomAD4 genome AF: 0.00233 AC: 355AN: 152286Hom.: 0 Cov.: 32 AF XY: 0.00200 AC XY: 149AN XY: 74452
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 27, 2018 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
ATP13A4-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 17, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at